Alphadyne Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Buy
+231,000
New +$6.04M 0.05% 309
2025
Q4
Sell
-32,300
Closed -$823K 890
2025
Q3
$823K Buy
32,300
+30,900
+2,207% +$763K 0.07% 208
2025
Q2
$33.9K Buy
+1,400
New +$32.6K 0.01% 162

Other funds holding PFE

Alphadyne Asset Management's PFE Position: Q2 2026 in Review

Alphadyne Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 18,508 shares worth $446K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in PFE as recently as Q2 2025.

Alphadyne Asset Management first reported a position in PFE in Q2 2023 and has held it in 4 quarters since. The position peaked at $2.34M in Q3 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Alphadyne Asset Management held 18,508 shares of Pfizer worth $446K as of Q2 2026.
  • Pfizer was a new Alphadyne Asset Management position in Q2 2026.
  • Pfizer made up ﹤0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #666 holding.
  • Alphadyne Asset Management first reported a position in Pfizer in Q2 2023 and has held it in 4 quarters since.
  • Alphadyne Asset Management's Pfizer position peaked at $2.34M in Q3 2023.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.